DExPri: Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)
Sponsor
LinkCare GmbH (Industry)
Overall Status
Completed
CT.gov ID
NCT04184596
Collaborator
Schmerzpraxis Wiesbaden (Other), Schmerz- und Palliativzentrum Rhein-Main Wiesbaden (Other), Grünenthal GmbH (Industry)
153
3
6.6
51
7.7
Study Details
Study Description
Brief Summary
The objective of this study is to identify and weight attributes of topic and systemic pain treatment options relevant from the patients' perspective with peripheral neuropathic pain. The study will use a discrete choice experimental design to reach its objective.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
153 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)
Actual Study Start Date
:
Feb 11, 2020
Actual Primary Completion Date
:
Jul 30, 2020
Actual Study Completion Date
:
Aug 31, 2020
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Stated-Preferences Observational Group A discrete choice experiment will be conducted with participants with peripheral neuropathic pain in the stated-preferences observational group. The instrument will measure patient preferences for topical versus systemic pain treatment. |
Other: Discrete Choice Experiment
An online-based Discrete-Choice Experiment (DCE) using a survey for stated treatment preferences and socio-demographics. Furthermore, the neuropathic pain component will be assessed in all patients with the Numeric Pain Rating Scale instrument.
|
Outcome Measures
Primary Outcome Measures
- Patient preferences for topical and systemic pain treatment attributes [20 minutes after survey start]
Utility values obtained via multinominal logit estimates from discrete choice experiment
Secondary Outcome Measures
- Relevance of attributes attributed with topical and systemic pain treatment [5 minutes after survey start]
Derived from Likert scale
- Marginal rate of substitution against pain reduction [20 minutes after survey start]
Derived from discrete choice experiment
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with diagnosed peripheral neuropathic pain (pNP) as assessed by study sites
Exclusion Criteria:
- Patients with no sufficient knowledge in written or oral German as assessed by study sites
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | LinkCare GmbH | Stuttgart | Baden-Württemberg | Germany | 70469 |
| 2 | Schmerz- und Palliativzentrum Rhein-Main | Wiesbaden | Hesse | Germany | 65189 |
| 3 | Schmerzpraxis Wiesbaden | Wiesbaden | Hesse | Germany | 65193 |
Sponsors and Collaborators
- LinkCare GmbH
- Schmerzpraxis Wiesbaden
- Schmerz- und Palliativzentrum Rhein-Main Wiesbaden
- Grünenthal GmbH
Investigators
- Study Chair: Tino Schubert, MSc, LinkCare GmbH
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
Responsible Party:
LinkCare GmbH
ClinicalTrials.gov Identifier:
NCT04184596
Other Study ID Numbers:
- VF/1014/1070
First Posted:
Dec 3, 2019
Last Update Posted:
Feb 21, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by LinkCare GmbH
Additional relevant MeSH terms: